Immunicum holds a Scientific Advice Meeting
Immunicum holds a Scientific Advice Meeting with the Medical Products Agency to discuss the upcoming clinical phase I/II trial in renal cell carcinoma and considers the conditions for initiating the trial to be very favorable.
Notice: Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /home/i/immunicu/www/wp-includes/functions.php on line 4805